(Q37953987)

25 August 2017

title

Nutritional determinants of cognitive aging and dementia (English)

1 reference

25 August 2017

0 references

1

Martha C Morris

1 reference

25 August 2017

publication date

9 November 2011

1 reference

Proceedings of the Nutrition Society

25 August 2017

published in

1 reference

25 August 2017

volume

71

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

1-13

1 reference

Docosahexaenoic acid block of neuronal voltage-gated K+ channels: subunit selective antagonism by zinc.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Bidirectional actions of docosahexaenoic acid on hippocampal neurotransmissions in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Diet and risk of dementia: Does fat matter?: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Caloric intake and the risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary fat intake and 6-year cognitive change in an older biracial community population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary fats and the risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary fat intake and cognitive decline in women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary cis-fatty acids that increase protein F1 phosphorylation enhance spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Effect of docosahexaenoic acid-fortified Chlorella vulgaris strain CK22 on the radial maze performance in aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Correlation between level of (n - 3) polyunsaturated fatty acids in brain phospholipids and learning ability in rats. A multiple generation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Cognitive impairment following high fat diet consumption is associated with brain inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Genetics of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Serum total cholesterol, statins and cognition in non-demented elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

The metabolic syndrome and development of cognitive impairment among older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Changes in folate, vitamin B12 and homocysteine associated with incident dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Vitamin B(12) and folate in relation to the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Frequency of subclinical heart disease in elderly persons with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

A controlled trial of homocysteine lowering and cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Evidence-based criteria in the nutritional context

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

A potential design flaw of randomized trials of vitamin supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Systemic tocopherols and F2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Mediterranean diet, Alzheimer disease, and vascular mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Relation of higher folate intake to lower risk of Alzheimer disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Analogues, ageing and aberrant assimilation of vitamin B12 in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Diet and Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Metabolic markers of cobalamin deficiency and cognitive function in normal older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Prospective study of plasma folate, vitamin B12, and cognitive function and decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Epidemiology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Folate, vitamin b(12), and homocysteine as risk factors for cognitive decline in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Alzheimer Disease in the US Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Mixed brain pathologies account for most dementia cases in community-dwelling older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Part II. Clinical diagnosis and course of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Adherence to a Mediterranean diet, cognitive decline, and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Mediterranean diet and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Nutrient transport systems in brain: 40 years of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Folate deprivation, the methionine cycle, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Plasma homocysteine levels and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Neurological complications of acquired cobalamin deficiency: clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Fish intake and the risk of incident heart failure: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary patterns and risk of dementia: the Three-City cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Fish consumption and cognitive decline with age in a large community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Fish consumption and stroke in men. 30-year findings of the Chicago Western Electric Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Fish consumption and risk of stroke. The Zutphen Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Intake of fish and omega-3 fatty acids and risk of stroke in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary fat intake and the risk of incident dementia in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Fish, meat, and risk of dementia: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Vascular risk factors and dementia in the general population aged >85 years: prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Serum lipid levels and cognitive change in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

The role of dietary n-6 and n-3 fatty acids in the developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Serum lipoprotein levels, statin use, and cognitive function in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Alzheimer's disease: the cholesterol connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans--a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Inhibition of inflammation and carcinogenesis in the lung and colon by tocopherols

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

A randomized trial of vitamin E supplementation and cognitive function in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Vitamin E and cognitive decline in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Vitamin E and C supplements and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary antioxidants and long-term risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Plasma carotenoids and tocopherols and cognitive function: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Antioxidant vitamin intake and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Role of antioxidants in health maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Oxidative damage in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

The aging stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Artériel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Neural mechanisms of ageing and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Intake of flavonoids and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Low vitamin B-12 status and risk of cognitive decline in older adults.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Folates and prevention of disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Dietary fish oil affects monoaminergic neurotransmission and behavior in rats

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Effect of food fortification on folic acid intake in the United States

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Changes in maze behavior of mice occur after sufficient accumulation of docosahexaenoic acid in brain.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Cobalamin, the stomach, and aging

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Methodological issues in the study of cognitive decline

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Vitamin E and neurological function: lessons from patients with abetalipoproteinaemia

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Oxidative stress and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Serum Cholesterol Response to Changes in Dietary Lipids

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Importance of n-3 fatty acids in health and disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Effect of dietary docosahexaenoic acid and phosphatidylcholine on maze behavior and fatty acid composition of plasma and brain lipids in mice

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Fish consumption and incidence of stroke: a meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Circulating folic acid in plasma: relation to folic acid fortification

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Criteria for the clinical diagnosis of Alzheimer's disease. Excerpts from the NINCDS-ADRDA Work Group report

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake

1 reference

https://api.crossref.org/works/10.1017%2FS0029665111003296

7 January 2021

10.1017/S0029665111003296

Identifiers

DOI

1 reference

25 August 2017

1 reference